Paclitaxel: An inhibitor of angiogenesis in a vascularized breast cancer

被引：0
|
作者：
Lau, D [1 ]
机构：
[1] Univ Calif Davis, Ctr Canc, Sacramento, CA 95817 USA
来源：
SEMINARS IN ONCOLOGY | 1999年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：12 / 12
页数：1
相关论文
共 50 条
  • [31] Angiogenesis inhibition in breast cancer
    Heidemann, E.
    ONKOLOGIE, 2011, 34 : 286 - 286
  • [32] Gemcitabine combined with paclitaxel or paclitaxel/trastuzumab in metastatic breast cancer
    Sledge, GW
    SEMINARS IN ONCOLOGY, 2003, 30 (02) : 19 - 21
  • [33] Gemcitabine plus paclitaxel in breast cancer
    Yardley, DA
    SEMINARS IN ONCOLOGY, 2005, 32 (04) : S14 - S21
  • [34] Paclitaxel and docetaxel in the treatment of breast cancer
    Saloustros, Emmanouel
    Mavroudis, Dimitris
    Georgoulias, Vassilis
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (15) : 2603 - 2616
  • [35] Breast cancer response to paclitaxel in vivo
    Symmans, WF
    DRUG RESISTANCE UPDATES, 2001, 4 (05) : 297 - 302
  • [36] PACLITAXEL (TAXOL) IN BREAST-CANCER
    ARBUCK, SG
    DORR, A
    FRIEDMAN, MA
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1994, 8 (01) : 121 - 140
  • [37] Vinorelbine and paclitaxel in advanced breast cancer
    Pronzato, P
    Gardin, G
    Tognoni, A
    Vigani, A
    Vaira, F
    Gasco, M
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S321 - S321
  • [38] Paclitaxel and doxorubicin in metastatic breast cancer
    Gehl, J
    Boesgaard, M
    Paaske, T
    Jensen, BV
    Dombernowsky, P
    SEMINARS IN ONCOLOGY, 1996, 23 (06) : 35 - 38
  • [39] Paclitaxel and carboplatin for advanced breast cancer
    Perez, EA
    Hartmann, LC
    SEMINARS IN ONCOLOGY, 1996, 23 (05) : 41 - 45
  • [40] Resistance to Intervention: Paclitaxel in Breast Cancer
    Dan, Vipin Mohan
    Raveendran, Reji Saradha
    Baby, Sabulal
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2021, 21 (10) : 1237 - 1268
12345